Multiple Myeloma - 29/03/15
Doi : 10.1016/j.cpet.2014.12.008
Resumen |
This article presents a review of multiple myeloma, precursor states, and related plasma cell disorders. The clinical roles of fluorodeoxyglucose PET/computed tomography (CT) and the potential to improve the management of patients with multiple myeloma are discussed. The clinical and research data supporting the utility of PET/CT use in evaluating myeloma and other plasma cell dyscrasias continues to grow.
El texto completo de este artículo está disponible en PDF.Keywords : Fluorodeoxyglucose, PET, PET/CT, Multiple myeloma, Monoclonal gammopathy, Plasmacytoma
Esquema
| Dr P.J. Peller is a consultant for GE Medical. |
© 2015
Elsevier Inc. Reservados todos los derechos.
Vol 10 - N° 2
P. 227-241 - avril 2015 Regresar al número
Artículo precedente
- Role of 2-Deoxy-2-[18F]-fluoro-d-glucose-PET/Computed Tomography in Lymphoma
- Sree Harsha Tirumani, Ann S. LaCasce, Heather A. Jacene
- PET/Computed Tomography and Patient Outcomes in Melanoma
- Eric M. Rohren
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?